Arnaud Boutan-Laroze

1.1k total citations
17 papers, 827 citations indexed

About

Arnaud Boutan-Laroze is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Arnaud Boutan-Laroze has authored 17 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Arnaud Boutan-Laroze's work include Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Treatment and Pharmacology (3 papers). Arnaud Boutan-Laroze is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Genetic factors in colorectal cancer (3 papers) and Cancer Treatment and Pharmacology (3 papers). Arnaud Boutan-Laroze collaborates with scholars based in France, Italy and Canada. Arnaud Boutan-Laroze's co-authors include Salomon Minkin, Pierre Ruffiè, Robert J. Ginsberg, R. Feld, A Figueredo, F. Shepherd, William K. Evans, Jean-Pierre Ayoub, Yvon Cormier and Thierry André and has published in prestigious journals such as Journal of Clinical Oncology, Kidney International and European Journal of Cancer.

In The Last Decade

Arnaud Boutan-Laroze

13 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arnaud Boutan-Laroze France 9 396 392 156 128 79 17 827
Ryosuke Nemoto Japan 17 293 0.7× 294 0.8× 239 1.5× 58 0.5× 85 1.1× 90 883
Matthew Tan United States 7 558 1.4× 210 0.5× 335 2.1× 155 1.2× 126 1.6× 10 1.1k
Hisateru Yasui Japan 15 545 1.4× 340 0.9× 150 1.0× 94 0.7× 201 2.5× 113 931
S. Bennis Morocco 15 198 0.5× 94 0.2× 144 0.9× 104 0.8× 99 1.3× 52 600
N. Mylonakis Greece 19 745 1.9× 456 1.2× 202 1.3× 79 0.6× 72 0.9× 65 1.1k
Dong Yi Kim South Korea 15 259 0.7× 435 1.1× 328 2.1× 52 0.4× 64 0.8× 43 896
Tarek Chidiac United States 11 802 2.0× 384 1.0× 102 0.7× 137 1.1× 32 0.4× 16 1.0k
Hiroyuki Deguchi Japan 13 153 0.4× 253 0.6× 172 1.1× 35 0.3× 93 1.2× 59 665
D. Bafaloukos Greece 13 566 1.4× 185 0.5× 102 0.7× 176 1.4× 37 0.5× 37 777
Takekazu Yamao Japan 9 274 0.7× 487 1.2× 210 1.3× 51 0.4× 133 1.7× 19 846

Countries citing papers authored by Arnaud Boutan-Laroze

Since Specialization
Citations

This map shows the geographic impact of Arnaud Boutan-Laroze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnaud Boutan-Laroze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnaud Boutan-Laroze more than expected).

Fields of papers citing papers by Arnaud Boutan-Laroze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnaud Boutan-Laroze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnaud Boutan-Laroze. The network helps show where Arnaud Boutan-Laroze may publish in the future.

Co-authorship network of co-authors of Arnaud Boutan-Laroze

This figure shows the co-authorship network connecting the top 25 collaborators of Arnaud Boutan-Laroze. A scholar is included among the top collaborators of Arnaud Boutan-Laroze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnaud Boutan-Laroze. Arnaud Boutan-Laroze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Karoui, Khalil El, Nelly Bosselut, Arnaud Boutan-Laroze, et al.. (2023). The Case | A paraneoplastic kidney injury?. Kidney International. 104(2). 401–402.
2.
André, Thierry, Emmanuel Quinaux, P. Colin, et al.. (2007). Phase III Study Comparing a Semimonthly With a Monthly Regimen of Fluorouracil and Leucovorin As Adjuvant Treatment for Stage II and III Colon Cancer Patients: Final Results of GERCOR C96.1. Journal of Clinical Oncology. 25(24). 3732–3738. 115 indexed citations
3.
André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). Traitement adjuvant du cancer du côlon : principaux résultats de l’étude MOSAIC*. Bulletin du Cancer. 93(2). 5–9. 1 indexed citations
4.
André, Thierry, Christophe Tournigand, Emmanuel Achille, et al.. (2006). [Adjuvant treatment of colon cancer MOSAIC study's main results].. PubMed. 93 Suppl 1. S5–9. 36 indexed citations
5.
André, Thierry, Philippe Colin, Christophe Louvet, et al.. (2003). Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial. Journal of Clinical Oncology. 21(15). 2896–2903. 185 indexed citations
6.
André, Thierry, P. Colin, Érick Gamelin, et al.. (2001). Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: Study design and preliminary safety results. Seminars in Oncology. 28(1 Suppl 1). 35–40. 17 indexed citations
7.
Sèze, J. de, Tunç Iyriboz, Arnaud Boutan-Laroze, & P Davous. (1994). [Cerebral hemorrhage disclosing metastatic choriocarcinoma].. PubMed. 150(4). 304–6. 3 indexed citations
8.
Kattan, Joseph, M. Mahjoubi, Jean‐Pierre Droz, et al.. (1993). High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours. European Journal of Cancer. 29(11). 1504–1509. 8 indexed citations
9.
Michel, G, et al.. (1993). Ovarian dysgerminoma metastatic to the breast. International Journal of Gynecology & Obstetrics. 41(1). 121–121.
10.
Kattan, Joseph, Jean‐Pierre Droz, Patrick Couvreur, et al.. (1992). Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Investigational New Drugs. 10(3). 191–199. 109 indexed citations
11.
Kattan, Joseph, Jean‐Pierre Droz, Vincent Ribrag, et al.. (1992). Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients. European Journal of Cancer. 28(4-5). 867–870. 4 indexed citations
12.
Kattan, Joseph, et al.. (1992). Ovarian dysgerminoma metastatic to the breast. Gynecologic Oncology. 46(1). 104–106. 12 indexed citations
13.
Boutan-Laroze, Arnaud, M. Mahjoubi, Jean‐Pierre Droz, et al.. (1991). M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. European Journal of Cancer and Clinical Oncology. 27(12). 1690–1694. 57 indexed citations
14.
Kattan, Joseph, Droz Jp, Arnaud Boutan-Laroze, et al.. (1991). [Choroid metastasis in a case of urothelial carcinoma metastatic from the bladder].. PubMed. 1(3). 466–9. 5 indexed citations
15.
Lépine, J, et al.. (1990). [8;21 translocation and leukemia].. PubMed. 118(6). 238–41. 1 indexed citations
16.
Beurton, D, et al.. (1990). [Urothelial carcinoma on vesico-renal bilharziosis with multiple bone metastases].. PubMed. 19(43). 1990–1.
17.
Ruffiè, Pierre, R. Feld, Salomon Minkin, et al.. (1989). Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.. Journal of Clinical Oncology. 7(8). 1157–1168. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryosuke Nemoto Breakdown of academic impact, for papers by Matthew Tan Breakdown of academic impact, for papers by Hisateru Yasui Breakdown of academic impact, for papers by S. Bennis Breakdown of academic impact, for papers by N. Mylonakis Breakdown of academic impact, for papers by Dong Yi Kim Breakdown of academic impact, for papers by Tarek Chidiac Breakdown of academic impact, for papers by Hiroyuki Deguchi Breakdown of academic impact, for papers by D. Bafaloukos Breakdown of academic impact, for papers by Takekazu Yamao
Rankless by CCL
2026